Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991353706> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W1991353706 endingPage "119" @default.
- W1991353706 startingPage "109" @default.
- W1991353706 abstract "A key problem in the effective treatment of patients with cancer (both leukemia and solid tumors) is to distinguish between tumor and normal cells. This problem is the main reason why current treatments for cancer are often ineffective. There have been remarkable advances in our understanding of the molecular biology of cancer that provides new selective tumor destruction mechanisms. The molecular characterization of the tumor-specific chromosomal abnormalities has revealed that fusion proteins are the consequence in the majority of cancers. These fusion proteins result from chimeric genes created by the translocations, which form chimeric mRNA species that contain exons from the genes involved in the translocation. Obviously, these chimeric molecules are attractive therapeutic targets since they are unique to the disease (they only exist in the tumor cells but not in the normal cells of the patient), allowing the design of specific anti-tumor drugs. Inhibition of chimeric gene expression by anti-tumor agents specifically kills leukemic cells without affecting normal cells. As therapeutic agents targeting chimeric genes, zinc-finger proteins, antisense RNAs or hammerhead-based ribozymes have been used. All of these agents have some limitations, indicating that new therapeutic tools are required as gene inactivating agents that should be able to inhibit any chimeric fusion gene product. Recently, we have used the catalytic RNA subunit of RNase P from Escherichia coli, which can be specifically directed to cut any mRNA sequence, to specifically destroy tumor-specific fusion genes created as a result of chromosomal translocations. In this chapter, we will review the advances made to selectively destroy tumor cells through specific inhibition of products resulting from chromosomal translocations." @default.
- W1991353706 created "2016-06-24" @default.
- W1991353706 creator A5009536384 @default.
- W1991353706 creator A5009656123 @default.
- W1991353706 creator A5033002324 @default.
- W1991353706 creator A5041002773 @default.
- W1991353706 creator A5042429220 @default.
- W1991353706 creator A5050182718 @default.
- W1991353706 creator A5068281117 @default.
- W1991353706 creator A5075974674 @default.
- W1991353706 date "2001-08-01" @default.
- W1991353706 modified "2023-10-01" @default.
- W1991353706 title "Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations" @default.
- W1991353706 doi "https://doi.org/10.2174/1568009013334214" @default.
- W1991353706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12188884" @default.
- W1991353706 hasPublicationYear "2001" @default.
- W1991353706 type Work @default.
- W1991353706 sameAs 1991353706 @default.
- W1991353706 citedByCount "5" @default.
- W1991353706 countsByYear W19913537062015 @default.
- W1991353706 countsByYear W19913537062016 @default.
- W1991353706 countsByYear W19913537062020 @default.
- W1991353706 countsByYear W19913537062023 @default.
- W1991353706 crossrefType "journal-article" @default.
- W1991353706 hasAuthorship W1991353706A5009536384 @default.
- W1991353706 hasAuthorship W1991353706A5009656123 @default.
- W1991353706 hasAuthorship W1991353706A5033002324 @default.
- W1991353706 hasAuthorship W1991353706A5041002773 @default.
- W1991353706 hasAuthorship W1991353706A5042429220 @default.
- W1991353706 hasAuthorship W1991353706A5050182718 @default.
- W1991353706 hasAuthorship W1991353706A5068281117 @default.
- W1991353706 hasAuthorship W1991353706A5075974674 @default.
- W1991353706 hasConcept C104317684 @default.
- W1991353706 hasConcept C111829193 @default.
- W1991353706 hasConcept C121608353 @default.
- W1991353706 hasConcept C123894998 @default.
- W1991353706 hasConcept C138626823 @default.
- W1991353706 hasConcept C150194340 @default.
- W1991353706 hasConcept C26260077 @default.
- W1991353706 hasConcept C40767141 @default.
- W1991353706 hasConcept C502942594 @default.
- W1991353706 hasConcept C54355233 @default.
- W1991353706 hasConcept C86803240 @default.
- W1991353706 hasConcept C96232424 @default.
- W1991353706 hasConceptScore W1991353706C104317684 @default.
- W1991353706 hasConceptScore W1991353706C111829193 @default.
- W1991353706 hasConceptScore W1991353706C121608353 @default.
- W1991353706 hasConceptScore W1991353706C123894998 @default.
- W1991353706 hasConceptScore W1991353706C138626823 @default.
- W1991353706 hasConceptScore W1991353706C150194340 @default.
- W1991353706 hasConceptScore W1991353706C26260077 @default.
- W1991353706 hasConceptScore W1991353706C40767141 @default.
- W1991353706 hasConceptScore W1991353706C502942594 @default.
- W1991353706 hasConceptScore W1991353706C54355233 @default.
- W1991353706 hasConceptScore W1991353706C86803240 @default.
- W1991353706 hasConceptScore W1991353706C96232424 @default.
- W1991353706 hasIssue "2" @default.
- W1991353706 hasLocation W19913537061 @default.
- W1991353706 hasLocation W19913537062 @default.
- W1991353706 hasOpenAccess W1991353706 @default.
- W1991353706 hasPrimaryLocation W19913537061 @default.
- W1991353706 hasRelatedWork W1519176158 @default.
- W1991353706 hasRelatedWork W187587110 @default.
- W1991353706 hasRelatedWork W1976631985 @default.
- W1991353706 hasRelatedWork W2031731997 @default.
- W1991353706 hasRelatedWork W2116232207 @default.
- W1991353706 hasRelatedWork W2416047383 @default.
- W1991353706 hasRelatedWork W2618189922 @default.
- W1991353706 hasRelatedWork W3162475615 @default.
- W1991353706 hasRelatedWork W4244240117 @default.
- W1991353706 hasRelatedWork W4308180770 @default.
- W1991353706 hasVolume "1" @default.
- W1991353706 isParatext "false" @default.
- W1991353706 isRetracted "false" @default.
- W1991353706 magId "1991353706" @default.
- W1991353706 workType "article" @default.